Adalimumab-Adaz
Adalimumab-adaz 2ML of 40MG/0.4ML
¿Qué es Adalimumab-Adaz?
Adalimumab-Adaz es un biosimilar de adalimumab, un anticuerpo monoclonal que se une al factor de necrosis tumoral (TNF), inhibiendo así su actividad y disminuyendo la inflamación en condiciones autoinmunes crónicas como la artritis reumatoide, la enfermedad de Crohn y la psoriasis. Está indicado para pacientes que requieren resultados terapéuticos y perfiles de seguridad similares al producto de referencia, ofreciendo una alternativa rentable para el manejo a largo plazo.Side Effects
- Unusual bleeding, bruising, tiredness, weakness, or weight loss
- Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
- Blistering, peeling, red skin rash
Warnings
- Keep all medicine out of the reach of children. Never share your medicine with anyone.
- Tell your doctor if you are pregnant or breastfeeding, or if you have liver disease, COPD, heart failure, diabetes, psoriasis, multiple sclerosis, optic neuritis, problems with your immune system, Guillain-Barré syndrome, or a history of cancer. Tell your doctor if you have any type of infection (including hepatitis B or tuberculosis) or an infection that keeps coming back.
- This medicine may cause the following problems: Increased risk for serious infectionsIncreased risk of certain cancers, including skin cancer, lymphoma, or leukemiaNew or worsening heart failureLupus-like syndrome
- Tell your doctor if you have a latex allergy. The gray needle cap of the prefilled syringe and the gray needle cover within the needle cap of the Sensoready® pen contains natural rubber latex and may cause allergic reactions.
- You will need to have a skin test for tuberculosis (TB) before you start using this medicine. Tell your doctor if you or anyone in your home has ever had a positive TB skin test or has been exposed to TB.
Prescription savings
Adalimumab-Adaz Cupones y Precios - Rx.com
Adalimumab-adaz 2ML of 40MG/0.4ML
¿Qué es Adalimumab-Adaz ?
Adalimumab-Adaz es un biosimilar de adalimumab, un anticuerpo monoclonal que se une al factor de necrosis tumoral (TNF), inhibiendo así su actividad y disminuyendo la inflamación en condiciones autoinmunes crónicas como la artritis reumatoide, la enfermedad de Crohn y la psoriasis. Está indicado para pacientes que requieren resultados terapéuticos y perfiles de seguridad similares al producto de referencia, ofreciendo una alternativa rentable para el manejo a largo plazo.
Medicamentos Relacionados
Browse more medications: starting with A · full A-Z directory · by condition · common drugs
Medical disclaimer: This information is provided for general educational purposes only and is not medical advice. It is not a substitute for professional diagnosis or treatment. Always consult a licensed physician, pharmacist, or other qualified healthcare provider before starting, stopping, or changing any medication or treatment. Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or 911 immediately.